MacroGenics, Inc.
MGNX
$1.31
-$0.06-4.38%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -140.17% | -639.30% | -295.96% | -1,930.74% | 74.55% |
| Total Depreciation and Amortization | -12.15% | -21.82% | -32.70% | -36.80% | -28.76% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 92.05% | 92.17% | 116.24% | 57.97% | -585.78% |
| Change in Net Operating Assets | -128.93% | -97.39% | -75.12% | -88.64% | 274.32% |
| Cash from Operations | 37.29% | 12.57% | -178.22% | -3,183.02% | -163.72% |
| Capital Expenditure | 3.07% | -110.09% | -141.12% | -96.15% | -11.57% |
| Sale of Property, Plant, and Equipment | 150.00% | 150.00% | 150.00% | 66.67% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 270.03% | 294.99% | 221.89% | 564.88% | -167.23% |
| Cash from Investing | 261.19% | 286.43% | 217.61% | 503.31% | -171.09% |
| Total Debt Issued | -- | -- | -- | -- | -200.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -75.02% | 193.84% | 57.50% | 62.27% | 41.21% |
| Repurchase of Common Stock | 85.58% | -708.82% | -707.52% | -1,317.88% | -1,376.16% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -100.00% | -49.75% | -- |
| Cash from Financing | -99.15% | -99.36% | -99.29% | -49.72% | -50.37% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 145.32% | 1,132.85% | 1,419.51% | -128.44% | -181.33% |